Baronsmead Second Venture Trust PLC (BMD), a venture capital trust managed by Gresham House, has disclosed that Non-Executive Director Sarah Katinka Fromson purchased ordinary shares in the company on 19 November 2026. The transaction was made under the Prospectus for Offers for Subscription issued in October 2026, representing a director-level participation in the trust's latest fundraising round. Such PDMR disclosures are required under UK market regulations and are closely watched by investors as signals of board-level confidence in the underlying portfolio.
Key Points
- Baronsmead Second Venture Trust PLC (BMD), LEI: 2138008D3WUMF6TW8C28
- Non-Executive Director Sarah Katinka Fromson purchased 5,000 ordinary shares on 19 November 2026
- Shares acquired at 47.28p each under the October 2026 Prospectus for Offers for Subscription, executed on the London Stock Exchange
- Investors may be watching for further director participation under the October 2026 prospectus offer and any update on funds raised
Sarah Fromson Purchases 5,000 BMD Shares at 47.28p Under October 2026 Prospectus
The announcement states that Sarah Katinka Fromson, serving as a Non-Executive Director of Baronsmead Second Venture Trust PLC, acquired 5,000 ordinary shares of £0.10 each at a price of 47.28p per share on 19 November 2026. The transaction was a single purchase conducted on the London Stock Exchange and carried out specifically under the Prospectus for Offers for Subscription issued by the company in October 2026. The shares carry ISIN GB0030028103. The total consideration paid by Fromson was not separately disclosed as an aggregated figure, as the announcement designates the transaction as a single deal rather than an aggregated position.
Baronsmead Second Venture Trust and Its Role as a UK Venture Capital Trust
Baronsmead Second Venture Trust is a UK-listed venture capital trust, a structure designed to channel retail investor capital into smaller, growth-orientated UK businesses whilst offering qualifying investors certain tax advantages under HMRC rules. The trust is operated under the Baronsmead VCT brand, with investor relations handled by Gresham House, a specialist alternative asset manager. VCTs are subject to strict regulatory requirements regarding the proportion of qualifying investments they must hold, and investor appetite for new VCT share offers is typically driven by annual tax planning cycles, particularly ahead of the tax year end.
Regulatory Context of PDMR Disclosure for BMD Investors
Under UK Market Abuse Regulation, persons discharging managerial responsibilities and their closely associated persons are legally required to notify both the company and the relevant regulator when they transact in the issuer's securities above applicable thresholds. This filing represents an initial notification, confirming no prior disclosure was made for this specific transaction. The disclosure was made public on 20 November 2026, one day after the transaction date. Investors may be watching whether further board members or senior personnel participate in the October 2026 prospectus offer before it closes.
October 2026 Prospectus Offer: Key Risk for Potential Subscribers
The October 2026 Prospectus for Offers for Subscription through which Fromson acquired her shares represents a live fundraising mechanism for Baronsmead Second Venture Trust. A key risk specific to this company and its VCT structure is that qualifying status for tax relief purposes depends on the trust maintaining required investment thresholds in eligible companies, which are typically early-stage and illiquid UK businesses. The total amount raised under this prospectus offer, and the offer's closing date, were not disclosed in this announcement. Investors considering participation should consult the full prospectus documentation directly.




Please wait processing your request...